Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Alto Neuroscience (ANRO) Other Operating Expenses (2023)

Alto Neuroscience has reported Other Operating Expenses over the past 1 years, most recently at $30.1 million for Q4 2023.

  • Quarterly results put Other Operating Expenses at $30.1 million for Q4 2023, changed N/A from a year ago — trailing twelve months through Sep 2024 was $30.1 million (changed N/A YoY), and the annual figure for FY2023 was $30.1 million, changed.
  • Other Operating Expenses reached $30.1 million in Q4 2023 per ANRO's latest filing.
  • Across five years, Other Operating Expenses topped out at $30.1 million in Q4 2023 and bottomed at $30.1 million in Q4 2023.